Janssen in Belgium was founded in 1953 by Dr Paul Janssen, with only one thing in mind: saving people’s lives through the development of better medicines. In 1961, the company was acquired by Johnson & Johnson. Sonja Willems, managing director of Janssen Benelux, discusses the company’s response to the COVID-19 pandemic, Janssen’s collaboration with the Belgian government, and the company’s support for the local R&D environment.
From early research and development, through manufacturing and drug delivery to the patient, our employees in Belgium make a significant contribution to the health of patients worldwide
